100% agree. IMO, if I were NP, I’d go almost
Post# of 148300
IMO, if I were NP, I’d go almost 100% at cancer. That is a huge indication considering the presence of CCR5 in metastatic cancers and solid tumors (I don’t remember the exact %, but I believe Dr. BP quoted a pretty high % at one point). That would mean increasing the number of sites, increasing enrollment, and possibly starting a few more phase 2 trials for specific cancers, such as prostate cancer or pancreatic cancer. Results from those trials cannot be denied as cancer is and will continue to be a popular topic because cancer is indiscriminate and can kill anyone of any age. Leronlimab has shown the ability to do this and the world needs to see the data.